BioStock: Redsense Medical aces Q1

Following strong growth in 2019, Redsense Medical has just announced their first quarter with a net-profit following a 154 per cent increase in revenues compared to the same period last year. The impressive numbers are linked to the rising knowledge of the need for anti-leakage alarms in dialysis treatment and an increasing trend towards performing dialysis in the home. The company sees prospects for continued growth and have, as of yet, noted limited setbacks from the Covid-19 pandemic.

Read the full article at biostock.se: 

https://www.biostock.se/en/redsense-medical-aces-q1/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se